Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Florida Cancer Specialists
mi
from
West Coast, FL
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Florida Cancer Specialists
mi
from
West Coast, FL
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Orchard Healthcare Research Inc.
mi
from
Skokie, IL
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Orchard Healthcare Research Inc.
mi
from
Skokie, IL
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Midwestern Regional Medical Center
mi
from
Zion, IL
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Midwestern Regional Medical Center
mi
from
Zion, IL
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Cancer Care of Louisiana
mi
from
New Orleans, LA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Cancer Care of Louisiana
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Henry Ford Health System
mi
from
Detroit, MI
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Montefiore-Einstein Cancer Center
mi
from
Bronx, NY
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Montefiore-Einstein Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Weill Cornell Breast Center/Weill Cornell Medical College
mi
from
New York, NY
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Weill Cornell Breast Center/Weill Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Levine Cancer Institute - Blumenthal Cancer Center
mi
from
Charlotte, NC
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Levine Cancer Institute - Blumenthal Cancer Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Center for Biomedical Research
mi
from
Knoxville, TN
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Center for Biomedical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Sarah Cannon Research Institution
mi
from
Nashville, TN
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Sarah Cannon Research Institution
mi
from
Nashville, TN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
St. Vincent Birmingham & St. Vincent East
mi
from
Birmingham, AL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
St. Vincent Birmingham & St. Vincent East
mi
from
Birmingham, AL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Jacksonville Center for Research
mi
from
Jacksonville, FL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Jacksonville Center for Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Moffit Cancer Center
mi
from
Tampa, FL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Moffit Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
WellStar Research Institute
mi
from
Atlanta, GA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
WellStar Research Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Emory University
mi
from
Atlanta, GA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Indiana University
mi
from
Indianapolis, IN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
St. Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
St. Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Greater Baltimore Medical Center
mi
from
Baltimore, MD
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Mass General Hospital
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Mass General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Brigham and Women's Hosp
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Beth Israel Deconess Medical Center
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Beth Israel Deconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Lancaster General Hospital
mi
from
Lancaster, PA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
VCU Medical Center
mi
from
Richmond, VA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Swedish Cancer Institute
mi
from
Seattle, WA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Dean Foundation for Health, Research and Education Inc.
mi
from
Madison, WI
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Dean Foundation for Health, Research and Education Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
UMass Memorial Medical
mi
from
Worcester, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
UMass Memorial Medical
mi
from
Worcester, MA
Click here to add this to my saved trials
Non-Invasive Imaging for Cording in Breast Cancer Patients
Evaluation of Non Invasive Imaging for Assessing the Pathophysiology of Cording in Patients Treated for Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Non-Invasive Imaging for Cording in Breast Cancer Patients
Evaluation of Non Invasive Imaging for Assessing the Pathophysiology of Cording in Patients Treated for Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
Status: Enrolling
Updated:  3/14/2016
Allegiance Health
mi
from
Jackson, MI
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
Status: Enrolling
Updated: 3/14/2016
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
Status: Enrolling
Updated:  3/14/2016
Huron Medical Center
mi
from
Port Huron, MI
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
Status: Enrolling
Updated: 3/14/2016
Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response
Status: Enrolling
Updated:  3/14/2016
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response
Status: Enrolling
Updated: 3/14/2016
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and Stage I Carcinoma of the Oral Cavity
Status: Enrolling
Updated:  3/14/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and Stage I Carcinoma of the Oral Cavity
Status: Enrolling
Updated: 3/14/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated:  3/14/2016
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated: 3/14/2016
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated:  3/14/2016
Alvarado Orthopedic Clinic
mi
from
San Diego, CA
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated: 3/14/2016
Alvarado Orthopedic Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated:  3/14/2016
American Health Network
mi
from
Avon, IN
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated: 3/14/2016
American Health Network
mi
from
Avon, IN
Click here to add this to my saved trials
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated:  3/14/2016
Raliegh Orthopedic Research Foundation
mi
from
Raleigh, NC
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
Status: Enrolling
Updated: 3/14/2016
Raliegh Orthopedic Research Foundation
mi
from
Raleigh, NC
Click here to add this to my saved trials
Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant
The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant
The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase II Study of Erlotinib (Tarceva®) and Radiotherapy for Elderly Patients With Esophageal Carcinoma
Status: Enrolling
Updated:  3/14/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase II Study of Erlotinib (Tarceva®) and Radiotherapy for Elderly Patients With Esophageal Carcinoma
Status: Enrolling
Updated: 3/14/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Billings, MT
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/14/2016
mi
from
Vancouver,
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/14/2016
mi
from
Vancouver,
Click here to add this to my saved trials
A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery
A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery
Status: Enrolling
Updated:  3/15/2016
Montefiore Medical Center
mi
from
Bronx, NY
A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery
A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery
Status: Enrolling
Updated: 3/15/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated:  3/15/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated: 3/15/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated:  3/15/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated: 3/15/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated:  3/15/2016
Lahey Clinic
mi
from
Burlington, MA
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Status: Enrolling
Updated: 3/15/2016
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials